98 related articles for article (PubMed ID: 2250194)
21. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
22. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters.
Tenti P; Zappatore R; Romagnoli S; Civardi E; Giunta P; Scelsi R; Stella G; Carnevali L
J Pathol; 1996 Jan; 178(1):65-70. PubMed ID: 8778319
[TBL] [Abstract][Full Text] [Related]
23. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population.
Castelli EC; Mendes-Junior CT; Viana de Camargo JL; Donadi EA
Tissue Antigens; 2008 Aug; 72(2):149-57. PubMed ID: 18721275
[TBL] [Abstract][Full Text] [Related]
24. The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.
Bulmer JN; Earl U
Immunology; 1987 Jun; 61(2):207-13. PubMed ID: 3298023
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
26. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
[TBL] [Abstract][Full Text] [Related]
27. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis.
Bacchi CE; Coelho KI; Goldberg J
Rev Paul Med; 1993; 111(3):412-6. PubMed ID: 8108635
[TBL] [Abstract][Full Text] [Related]
28. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, and DQ) in human fetal adrenal, pancreas, thyroid, and gut.
Oliver AM; Sewell HF; Abramovich DR; Thomson AW
Transplant Proc; 1989 Feb; 21(1 Pt 1):651-2. PubMed ID: 2495628
[No Abstract] [Full Text] [Related]
29. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
30. [Allogenic cartilage transplantation--immunohistochemical investigations on the antigenicity of the perichondrium].
Bujia J; Wilmer E; Hammer C; Kastenbauer E
Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):202-4. PubMed ID: 2095644
[TBL] [Abstract][Full Text] [Related]
31. Class I and class II HLA antigen expression by transitional cell carcinoma of the bladder: correlation with T-cell infiltration and BCG treatment.
Stefanini GF; Bercovich E; Mazzeo V; Grigioni WF; Emili E; D'Errico A; Lo Cigno M; Tamagnini N; Mazzetti M
J Urol; 1989 Jun; 141(6):1449-53. PubMed ID: 2657113
[TBL] [Abstract][Full Text] [Related]
32. Immunology of the bladder.
Graham SD
Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
[TBL] [Abstract][Full Text] [Related]
33. Expression of HLA-D sub-region products on human colorectal carcinoma.
Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
35. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
Momburg F; Herrmann B; Moldenhauer G; Möller P
Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
[TBL] [Abstract][Full Text] [Related]
36. Types of HLA in the bladder transitional cell carcinoma (TCC).
Yılmaz E; Uğur Özalp A; Cekmen A; Eren B; Onal B; Akkuş E; Erdoğan E
Med Glas (Zenica); 2013 Feb; 10(1):133-6. PubMed ID: 23348175
[TBL] [Abstract][Full Text] [Related]
37. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis.
Broomé U; Glaumann H; Hultcrantz R; Forsum U
Scand J Gastroenterol; 1990 Jan; 25(1):54-8. PubMed ID: 2406888
[TBL] [Abstract][Full Text] [Related]
38. Products of class II major histocompatibility complex gene subregions are differentially expressed on keratinocytes in cutaneous diseases.
Barker JN; Ophir J; MacDonald DM
J Am Acad Dermatol; 1988 Oct; 19(4):667-72. PubMed ID: 2460509
[TBL] [Abstract][Full Text] [Related]
39. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
40. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
Nouri AM; Thompson C; Cannell H; Symes M; Purkiss S; Amirghofran Z
Int J Mol Med; 2000 Oct; 6(4):495-500. PubMed ID: 10998445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
